HR Execs on the Move

Columbine Health Systems

www.columbinehealth.com

 
Columbine Health Systems is one of the leading companies in Healthcare, Pharmaceuticals, & Biotech industry. Columbine Health Systems is based in Loveland, CO. You can find more information on Columbine Health Systems at www.columbinehealth.com
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

AppleCare Medical Group

AppleCare Medical Group is a Artesia, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Gradworks-Lifecycle marketing and Education

Gradworks-Lifecycle marketing and Education is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Everly Health

Home health testing has never been easier. Order at-home tests directly to your door and get your results online within days.

HMS

HMS® (NASDAQ: HMSY) advances the healthcare system by helping healthcare organizations reduce costs and improve health outcomes. Through our industry-leading technology, analytics and engagement solutions, we save billions of healthcare dollars annually while helping consumers lead healthier lives. HMS provides a broad range of coordination of benefits, payment integrity and population health management solutions that help move the healthcare system forward.

Relmada

Relmada Therapeutics (OTCQB: RLMD) is a clinical-stage, publicly traded specialty pharmaceutical company developing novel versions of proven drug products together with new chemical entities that potentially address areas of high unmet medical need in the treatment of chronic pain. Relmada has a diversified portfolio of four lead products at various stages of development including d-Methadone (REL-1017) its N-methyl-D-aspartate (NMDA) receptor antagonist for neuropathic pain; topical mepivacaine (REL-1021), its orphan drug designated topical formulation of the local anesthetic mepivacaine; oral buprenorphine (REL-1028) its oral dosage form of the opioid analgesic buprenorphine; and LevoCap ER (REL-1015), its abuse resistant, sustained release dosage form of the opioid analgesic levorphanol. Relmada`s product development efforts are guided by the internationally recognized scientific expertise of our research team. Relmada`s approach is expected to reduce clinical development risks and costs while potentially delivering valuable products in areas of high unmet medical needs.